Skip to main content

Table 3 SSCP score before and after the intervention

From: Scale development and an educational program to reduce the stigma of schizophrenia among community pharmacists: a randomized controlled trial

  Educational lecture group Contact-based intervention group   
n = 56 n = 59   
Baseline Post-test pa Difference Baseline Post-test pa Difference pb Effect size
SSCP, median
(inter-quartile range)
74.0
(67.0–82.0)
69.0
(64.3–77.8)
< 0.001 −3.0
(−7.0–1.0)
71.0
(66.0–80.0)
62.0
(54.0–67.0)
< 0.001 −9.0
(−16.0−−5.0)
< 0.001 0.41
Factor I, median
(inter-quartile range)
32.0
(29.0–37.0)
29.5
(26.0–35.0)
< 0.001 −1.0
(− 5.0–0)
31.0
(26.0–36.0)
25.0
(22.0–30.0)
< 0.001 −4.0
(−9.0−−2.0)
0.001 0.32
Factor II, median
(inter-quartile range)
20.0
(18.0–22.0)
18.0
(17.0–21.8)
0.02 −1.0
(− 2.8–1.0)
20.0
(18.0–22.0)
16.0
(12.0–18.0)
< 0.001 −5.0
(−7.0−−2.0)
< 0.001 0.49
Factor III, median
(inter-quartile range)
12.0
(9.0–14.0)
11.0
(9.0–13.0)
0.01 −1.0
(−2.0–0)
11.0
(9.0–13.0)
10.0
(8.0–12.0)
0.04 −1.0
(−2.0–1.0)
0.94 0.01
Factor IV, median
(inter-quartile range)
10.0
(9.0–11.8)
10.0
(9.0–11.0)
0.52 0.0
(−1.0–1.0)
10.0
(8.0–12.0)
9.0
(8.0–10.0)
0.35 0.0
(−1.0–1.0)
0.18 0.13
  1. a: vs. each baseline
  2. b: vs. Lecture group
  3. Factor I: social distance at professional pharmacy service
  4. Factor II: attitudes towards patients diagnosed with schizophrenia
  5. Factor III: self-disclosure
  6. Factor IV: social distance in personal
  7. Statistical analysis was performed using the Wilcoxon signed-rank test or Mann-Whitney U test